Aspen Aerogels, Inc. (NYSE:ASPN) Receives Consensus Recommendation of “Hold” from Analysts

Aspen Aerogels, Inc. (NYSE:ASPN) has earned a consensus rating of “Hold” from the ten brokerages that are covering the company, Marketbeat reports. Three research analysts have rated the stock with a sell rating, two have issued a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $12.6667.

ASPN has been the topic of several analyst reports. Canaccord Genuity Group reduced their price objective on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a research note on Friday, November 7th. Zacks Research lowered Aspen Aerogels from a “hold” rating to a “strong sell” rating in a research report on Monday, November 10th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Monday, December 29th. Finally, Barclays cut their target price on shares of Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating on the stock in a research note on Friday, November 7th.

Insider Buying and Selling at Aspen Aerogels

In other news, CEO Donald R. Young sold 56,845 shares of Aspen Aerogels stock in a transaction on Thursday, November 13th. The shares were sold at an average price of $3.23, for a total transaction of $183,609.35. Following the completion of the sale, the chief executive officer directly owned 494,011 shares of the company’s stock, valued at approximately $1,595,655.53. The trade was a 10.32% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 4.30% of the company’s stock.

Institutional Trading of Aspen Aerogels

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Gagnon Securities LLC acquired a new stake in shares of Aspen Aerogels during the 2nd quarter worth about $11,243,000. Y Intercept Hong Kong Ltd purchased a new position in Aspen Aerogels in the second quarter valued at approximately $484,000. Palogic Value Management L.P. raised its holdings in Aspen Aerogels by 43.5% during the second quarter. Palogic Value Management L.P. now owns 610,000 shares of the construction company’s stock worth $3,611,000 after purchasing an additional 185,000 shares in the last quarter. Federated Hermes Inc. purchased a new stake in shares of Aspen Aerogels during the 2nd quarter worth approximately $10,459,000. Finally, SG Americas Securities LLC boosted its holdings in shares of Aspen Aerogels by 98.6% in the 2nd quarter. SG Americas Securities LLC now owns 133,821 shares of the construction company’s stock valued at $792,000 after buying an additional 66,427 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Aspen Aerogels Stock Performance

NYSE ASPN opened at $3.31 on Monday. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.94 and a quick ratio of 3.33. The company has a market cap of $273.16 million, a P/E ratio of -0.89 and a beta of 2.94. The stock has a 50-day moving average of $3.46 and a two-hundred day moving average of $5.92. Aspen Aerogels has a 1-year low of $2.80 and a 1-year high of $13.28.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Thursday, November 6th. The construction company reported ($0.06) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.05). Aspen Aerogels had a negative net margin of 86.52% and a negative return on equity of 0.20%. The business had revenue of $73.02 million during the quarter, compared to analysts’ expectations of $73.42 million. During the same period in the previous year, the business posted ($0.17) EPS. The company’s revenue for the quarter was down 37.8% compared to the same quarter last year. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. As a group, analysts anticipate that Aspen Aerogels will post 0.17 EPS for the current year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.